...
首页> 外文期刊>Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences >A Nonadhesive Liquid Embolic Agent of Ethylene Vinyl Alcohol Copolymer and Ethanol Mixture for Cerebral Arteriovenous Malformations Clinical Experience
【24h】

A Nonadhesive Liquid Embolic Agent of Ethylene Vinyl Alcohol Copolymer and Ethanol Mixture for Cerebral Arteriovenous Malformations Clinical Experience

机译:乙烯-乙烯醇共聚物和乙醇混合物的非粘性液体栓塞剂治疗脑动静脉畸形的临床经验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report our experience using our new non-adhesive liquid embolic agent, an ethylene vinyl alcohol copolymer (EVAL)/Ethanol mixture, to treat human arteriovenous malformations (AVM). Between June 1995 and April 2001, 57 patients with confirmed AVM underwent em-bolization with the EVAL/Ethanol mixture. Using 87 procedures consisting of one to three stages, we embolized 185 feeding arteries to occlude as much of the AVM as possible. Repeated injections under fluoroscopic control could be performed smoothly without encountering cementing of the catheter in the vessel wall.Among 87 procedures undertaken in 57 patients, seven (8.0%) procedures in six patients produced new postembolization symptoms. Resolution of these symptoms occurred within hours or days following four of the seven procedures; permanent neurological deficits remained after three embolization procedures (3.4%). Of the 57 patients, three underwent postembolization radiosurgery, 54 were radically treated with microsurgical extirpation.Histopathological examinations of the 54 specimens disclosed mild inflammation within the embolized lumen without inflammatory reactions in the media or adventitia. Follow-up angiograms obtained three years after they underwent radiosurgery showed that in all three patients the nidus had completely disappeared.The EVAL/Ethanol mixture is handled easily and appears to be an effective and safe embolic agent for the preoperative embolization of AVM.
机译:我们报告了使用我们的新型非粘性液体栓塞剂(乙烯-乙烯醇共聚物(EVAL)/乙醇混合物)治疗人类动静脉畸形(AVM)的经验。在1995年6月至2001年4月之间,对57例确诊为AVM的患者进行了EVAL /乙醇混合物的代谢治疗。我们使用87个由一到三个阶段组成的程序,栓塞了185个饲养动脉,以尽可能多地阻塞AVM。在荧光镜控制下重复注射可以顺利进行,而不会遇到导管在血管壁上的粘连.57例患者中进行了87例手术,其中6例中有7例(8.0%)产生了新的栓塞后症状。这些症状的缓解在七个步骤中的四个步骤后的数小时或数天内发生;三种栓塞手术后仍存在永久性神经功能缺损(3.4%)。在这57例患者中,有3例接受了栓塞后放射外科手术,其中54例接受了显微外科手术根治术.54例标本的组织病理学检查显示,栓塞腔内有轻度炎症,而在介质或外膜中没有炎性反应。接受放射外科手术三年后获得的后续血管造影照片显示,所有三名患者中的病灶均已完全消失。EVAL/乙醇混合物易于操作,似乎是AVM术前栓塞的一种有效且安全的栓塞剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号